| Product NDC: | 16252-536 |
| Proprietary Name: | Cabergoline |
| Non Proprietary Name: | Cabergoline |
| Active Ingredient(s): | .5 mg/1 & nbsp; Cabergoline |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 16252-536 |
| Labeler Name: | Cobalt Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078035 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080421 |
| Package NDC: | 16252-536-08 |
| Package Description: | 1 BOTTLE, PLASTIC in 1 CARTON (16252-536-08) > 8 TABLET in 1 BOTTLE, PLASTIC |
| NDC Code | 16252-536-08 |
| Proprietary Name | Cabergoline |
| Package Description | 1 BOTTLE, PLASTIC in 1 CARTON (16252-536-08) > 8 TABLET in 1 BOTTLE, PLASTIC |
| Product NDC | 16252-536 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cabergoline |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20080421 |
| Marketing Category Name | ANDA |
| Labeler Name | Cobalt Laboratories |
| Substance Name | CABERGOLINE |
| Strength Number | .5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] |